WallStSmart
ISPC

iSpecimen Inc

NASDAQ: ISPC · HEALTHCARE · DIAGNOSTICS & RESEARCH

$3.97
-2.28% today

Updated 2026-06-03

Market cap
$4.34M
P/E ratio
P/S ratio
4.22x
EPS (TTM)
$-329.05
Dividend yield
52W range
$3 – $103
Volume
26.8M

iSpecimen Inc (ISPC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20182019202020212022202320242025
Operating cash flow$-2.68M$-2.68M$-288380.00$-10.67M$-5.82M$-5.81M$-8.26M$-4.24M
Capital expenditures$1.03M$1.48M$1.10M$1.04M$3.19M$4.74M$56547.00$454.00
Depreciation$469173.00$634965.00$819687.00$1.00M$1.21M$2.12M$2.29M
Stock-based comp$113921.00$360379.00$92866.00$622064.00$678613.00$459666.00$249675.00$21266.00
Free cash flow$-3.71M$-4.16M$-1.39M$-11.71M$-9.01M$-10.55M$-8.32M$-4.24M
Investing cash flow$-1.03M$-1.48M$-1.10M$-1.04M$-3.19M$-7.23M$1.98M
Financing cash flow$3.52M$3.08M$2.03M$38.75M$-3.42M$70889.00$5.82M
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is iSpecimen Inc's revenue?

iSpecimen Inc's trailing twelve-month revenue is $1.03M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ISPC?

In its most recent fiscal year, ISPC ran a gross margin of 1.25%, an operating margin of -465.42%, and a net margin of -543.68%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ISPC generate?

ISPC produced $-4.24M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ISPC's balance sheet healthy?

ISPC holds $6.88M in cash and equivalents against — in long-term debt, on $3.09M of shareholder equity. That debt is best read against the cash flow the business throws off each year.